A trace of blood in the stool, a mild stomach ache, and a persistent urge to pass motion. Most Malaysians would dismiss these ...

Exact Sciences has a multipronged approach to cancer testing. Its flagship product line is Cologuard, the market leader in stool-based screening for colorectal cancer, or CRC. Its second-largest ...

The second-most common cancer in Malaysia may not have symptoms, which is why experts advocate checkups for early detection.

Simone Ledward Boseman secretly married Chadwick Boseman before his August 2020 death. Here's everything to know about ...

Exact Sciences markets Cologuard as a non-invasive, convenient test. The traditional method of testing for colorectal cancer ...

The medical-device giant's $21 bln acquisition of Exact Sciences will generate few synergies and only a 2% shorter-term ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and ...

Five AI-based technologies that can be used during a colonoscopy exam to help detect the early signs of bowel cancer have ...

Abbott Laboratories to acquire cancer diagnostics company for $105 per share in deal valued at $21 billion. Closing expected Q2 2026.

Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences.

Abbott said on Thursday it would buy cancer test maker Exact Sciences in a deal valued at up to $23 billion, including debt, ...

Business Insider's exclusive analysis shows colon cancer in your 30s can cost $45,000 in one year alone. We break it down, ...